Q1 2024 · 13F-HR
Column Group LLCholdings as filed
Filed 2024-05-15 · accession 0000950123-24-005685
$160.5M
Reported value
7
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $49.2M | 30.6% | 9,400,290 | Common | SOLE |
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $48.7M | 30.3% | 3,540,777 | Common | SOLE |
| 62921N105 | NGMUSD | NGM Biopharmaceuticals Inc | $28.8M | 18.0% | 18,136,735 | Common | SOLE |
| 75382E109 | — | RAPT Therapeutics Inc | $24.1M | 15.0% | 2,680,621 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $9.7M | 6.03% | 616,540 | Common | SOLE |
| 786700104 | SGMT | Sagimet Biosciences Inc. | $93,056 | 0.06% | 17,169 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $1,483 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.